tiprankstipranks
Advertisement
Advertisement

HK:2126 Stock Latest News

JW Therapeutics Boosts 2025 Revenue on CAR-T Sales and Licensing but Books Major Pipeline Impairments
Company AnnouncementsJW Therapeutics Boosts 2025 Revenue on CAR-T Sales and Licensing but Books Major Pipeline Impairments
18d ago
JW Therapeutics Schedules Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
JW Therapeutics Schedules Board Meeting to Approve 2025 Results and Consider Dividend
1M ago
JW Therapeutics Grants New Share Options and RSUs to CEO and Key Staff
PremiumCompany Announcements
JW Therapeutics Grants New Share Options and RSUs to CEO and Key Staff
3M ago
JW Therapeutics Outlines Board and Committee Structure
PremiumCompany Announcements
JW Therapeutics Outlines Board and Committee Structure
4M ago
JW Therapeutics Extends Vector Supply Agreement With Juno to 2028
PremiumCompany Announcements
JW Therapeutics Extends Vector Supply Agreement With Juno to 2028
4M ago
JW Therapeutics Announces Key Leadership Changes
PremiumCompany AnnouncementsJW Therapeutics Announces Key Leadership Changes
4M ago
JW Therapeutics Announces Board Composition and Roles
Premium
Company Announcements
JW Therapeutics Announces Board Composition and Roles
4M ago
JW Therapeutics Reports Promising Results for JWCAR201 in Hematology Study
Premium
Company Announcements
JW Therapeutics Reports Promising Results for JWCAR201 in Hematology Study
4M ago
JW Cayman and Regeneron Amend Collaboration for Oncology Product Development
PremiumCompany Announcements
JW Cayman and Regeneron Amend Collaboration for Oncology Product Development
6M ago
JW Therapeutics Advances SLE Treatment with Promising Phase I Results
PremiumCompany Announcements
JW Therapeutics Advances SLE Treatment with Promising Phase I Results
6M ago
JW Therapeutics Advances with In-House Lentiviral Vector for Carteyva®
PremiumCompany Announcements
JW Therapeutics Advances with In-House Lentiviral Vector for Carteyva®
6M ago
JW Therapeutics Delays Circular Dispatch for Incentivization Scheme
PremiumCompany Announcements
JW Therapeutics Delays Circular Dispatch for Incentivization Scheme
7M ago
JW Therapeutics Announces Share Options Grant to CEO
PremiumCompany AnnouncementsJW Therapeutics Announces Share Options Grant to CEO
7M ago
JW Therapeutics Reports Revenue Growth Amid Operational Improvements
Premium
Company Announcements
JW Therapeutics Reports Revenue Growth Amid Operational Improvements
8M ago
JW Therapeutics to Review Interim Results in Upcoming Board Meeting
Premium
Company Announcements
JW Therapeutics to Review Interim Results in Upcoming Board Meeting
8M ago
JW Therapeutics Announces Unanimous Approval of AGM Resolutions
PremiumCompany Announcements
JW Therapeutics Announces Unanimous Approval of AGM Resolutions
10M ago
JW Therapeutics Approves License Agreement at EGM
PremiumCompany Announcements
JW Therapeutics Approves License Agreement at EGM
10M ago
JW Therapeutics Advances Cancer Treatment with NMPA Acceptance
PremiumCompany Announcements
JW Therapeutics Advances Cancer Treatment with NMPA Acceptance
11M ago
JW Therapeutics Announces Extraordinary General Meeting for License Agreement Approval
PremiumCompany Announcements
JW Therapeutics Announces Extraordinary General Meeting for License Agreement Approval
11M ago
JW Therapeutics Announces Closure of Register for Upcoming EGM
PremiumCompany AnnouncementsJW Therapeutics Announces Closure of Register for Upcoming EGM
11M ago
JW Therapeutics Announces 2025 Annual General Meeting
Premium
Company Announcements
JW Therapeutics Announces 2025 Annual General Meeting
11M ago
JW Therapeutics Announces License Agreement with Juno Amid Regulatory Approvals
Premium
Company Announcements
JW Therapeutics Announces License Agreement with Juno Amid Regulatory Approvals
12M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >